• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

Introduction to 2-Fluoro-3-iodo-5-phenylpyridine (CAS No: 928822-81-5)

2-Fluoro-3-iodo-5-phenylpyridine, with the chemical identifier CAS No. 928822-81-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyridine class of heterocyclic aromatic compounds, which are widely recognized for their diverse biological activities and potential therapeutic applications. The structural features of 2-Fluoro-3-iodo-5-phenylpyridine, particularly the presence of a fluorine atom, an iodine substituent, and a phenyl group, make it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The significance of this compound lies in its versatility as a building block in drug discovery. The fluorine atom, being electronegative, can influence the electronic properties of the molecule, thereby modulating its interactions with biological targets. Similarly, the iodine substituent provides a handle for further functionalization through cross-coupling reactions, such as Suzuki or Stille couplings, which are commonly employed in constructing complex molecular architectures. The phenyl ring contributes to the overall lipophilicity and binding affinity of the compound, making it an attractive candidate for developing novel therapeutic agents.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting various disease pathways. 2-Fluoro-3-iodo-5-phenylpyridine has emerged as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinases. These kinases play crucial roles in signal transduction pathways and are implicated in numerous diseases, including cancer. The ability to modify the structure of 2-Fluoro-3-iodo-5-phenylpyridine allows researchers to fine-tune its binding properties, leading to the development of more potent and selective inhibitors.

Moreover, the growing interest in fluorinated compounds stems from their enhanced metabolic stability and bioavailability compared to their non-fluorinated counterparts. This property has made fluorinated pyridines particularly valuable in drug design. For instance, studies have demonstrated that fluorine substitution can improve the pharmacokinetic profile of drug candidates by increasing their resistance to enzymatic degradation. This has led to several fluorinated pyridines being investigated as lead compounds for new therapies.

The role of 2-Fluoro-3-iodo-5-phenylpyridine extends beyond kinase inhibition. It has also been explored as a precursor in the synthesis of antiviral and antibacterial agents. The structural motif present in this compound can be incorporated into molecules that target viral proteases or bacterial enzymes essential for their survival. Such applications highlight its broad utility in medicinal chemistry.

The synthesis of 2-Fluoro-3-iodo-5-phenylpyridine typically involves multi-step organic transformations starting from readily available pyridine derivatives. The introduction of the fluorine atom is often achieved through halogen exchange reactions or direct fluorination methods. The iodination step is commonly performed using iodinating agents such as N-Iodosuccinimide (NIS) or molecular iodine under appropriate conditions. Finally, the phenyl group is introduced via cross-coupling reactions with aryl halides or boronic acids.

The purity and yield of 2-Fluoro-3-iodo-5-phenylpyridine are critical factors that influence its downstream applications. High-performance liquid chromatography (HPLC) and gas chromatography (GC) are frequently employed for purification, ensuring that impurities do not interfere with subsequent synthetic steps or biological evaluations. Advances in synthetic methodologies have also enabled more efficient and scalable production processes for this compound.

In conclusion, 2-Fluoro-3-iodo-5-phenoypyridine (CAS No: 92882281) represents a significant advancement in pharmaceutical chemistry due to its versatile structural features and broad applicability in drug discovery. Its role as an intermediate in synthesizing kinase inhibitors, antiviral agents, and other therapeutic molecules underscores its importance in modern medicinal research. As our understanding of disease mechanisms continues to evolve, compounds like this will remain at the forefront of efforts to develop innovative treatments for human health.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)